The class of chemicals listed as Myosin Vc Activators includes various compounds that indirectly influence Myosin Vc through their effects on the cytoskeleton, cellular transport mechanisms, and related signaling pathways. These compounds are not direct activators of Myosin Vc but may impact its function by modulating the cellular environment and processes related to cytoskeletal dynamics.Actin dynamics modulators such as Jasplakinolide, Cytochalasin D, and Latrunculin A affect the structure and function of actin filaments, which are integral to the operation of myosin proteins, including Myosin Vc. These compounds can indirectly affect Myosin Vc function by altering the actin cytoskeleton.
Inhibitors of other myosin proteins or kinases involved in myosin regulation, like Blebbistatin (myosin II inhibitor) and ML-7 (myosin light chain kinase inhibitor), might also have indirect effects on Myosin Vc by altering overall myosin dynamics and phosphorylation states in cells.Compounds affecting microtubule dynamics, such as Nocodazole, Paclitaxel, Colchicine, and Vinblastine, can influence cellular transport mechanisms. While these primarily target microtubules, their impact on cellular transport can indirectly influence Myosin Vc activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
Blebbistatin, a myosin II inhibitor, may indirectly influence Myosin Vc activity by altering overall myosin dynamics in cells. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632, a ROCK inhibitor, might indirectly impact Myosin Vc function by modulating cytoskeletal dynamics and cell motility. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
Wiskostatin, an inhibitor of N-WASP, may indirectly influence Myosin Vc by affecting actin polymerization and cellular transport. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole, a microtubule-depolymerizing agent, may affect Myosin Vc indirectly by altering microtubule dynamics and associated transport pathways. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Paclitaxel, a microtubule stabilizer, could influence Myosin Vc indirectly by affecting microtubule-based transport mechanisms. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine, which disrupts microtubule polymerization, might have an indirect impact on Myosin Vc function in cellular transport. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
Vinblastine, a microtubule destabilizer, may indirectly affect Myosin Vc activity by influencing microtubule dynamics. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000C | 10 µg 100 µg 1 mg | $160.00 $750.00 $3000.00 | 59 | |
Calyculin A, a phosphatase inhibitor, could indirectly impact Myosin Vc by modulating phosphorylation states within the cell, affecting cytoskeletal dynamics. | ||||||